BFCFSI
OGEN icon

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.’s Oragenics OGEN Stock Holding History

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.’s Portfolio OGEN Stock Details OGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$1 – 2663
2025
Q4 		$1 Hold
1
– – ﹤0.01% 2672
2025
Q3 		$1 Hold
1
– – ﹤0.01% 2424
2025
Q2 		$4 Buy
+1
New +$5 ﹤0.01% 2347
2025
Q1 		– Hold
0
– – – 2313
2024
Q4 		– Hold
0
– – – 2213
2024
Q3 		– Hold
0
– – – 2170

Other funds holding OGEN

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
Two Sigma Securities
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return
HRT Financial
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Virtu Financial
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Ameritas Advisory Services
Ameritas Advisory Services Lincoln, Nebraska $5.22B AUM 19.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
St. Johns Investment Management
St. Johns Investment Management Jacksonville, Florida $263M AUM 21.67% 1-Year Est. Return

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s OGEN Position: Q1 2026 in Review

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. sold out of Oragenics (OGEN) in Q1 2026, closing a stake of 1 share — an estimated $1 sold.

BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. first reported a position in OGEN in Q2 2025 and held it in 3 quarters. The position peaked at $4 in Q2 2025. 20 funds tracked by Wall St. Rank hold OGEN as of Q1 2026.

  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. reported no remaining Oragenics position as of Q1 2026 after selling out during the quarter.
  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. sold 1 Oragenics share in Q1 2026, an estimated $1.
  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC. first reported a position in Oragenics in Q2 2025 and held it in 3 quarters.
  • BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s Oragenics position peaked at $4 in Q2 2025.
  • 20 funds tracked by Wall St. Rank held Oragenics as of Q1 2026.

Based on BERTHEL, FISHER & COMPANY FINANCIAL SERVICES, INC.'s 13F filing for Q1 2026, filed 30 Oct 2026.